Jushi Holdings (JUSHF) Share-based Compensation (2021 - 2026)
Jushi Holdings (JUSHF) reported Share-based Compensation of $392000.0 for Q1 2026, up 227.69% year-over-year from $119626.2 in Q1 2025, and down 76.68% quarter-over-quarter from $1.7 million in Q4 2025.
Jushi Holdings (JUSHF) Share-based Compensation (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Share-based Compensation data on file, last reported at $392000.0 in Q1 2026.
- Share-based Compensation for Q1 2026 came in at $392000.0, up 227.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.8 million (up 17.27% YoY), and the FY2025 annual result was $2.1 million, down 50.14% from the prior year.
- Share-based Compensation eased to $392000.0 in Q1 2026 per JUSHF's latest filing, from $1.7 million in the prior quarter.
- Over five years, Share-based Compensation peaked at $7.0 million in Q1 2022 and troughed at -$307000.0 in Q1 2025.
- A 5-year average of $2.2 million and a median of $1.5 million in 2024 frame the typical range for Share-based Compensation.
- The sharpest annual moves came in 2025 and 2026: Share-based Compensation tumbled 120.14% in 2025, then soared 227.69% in 2026.
- A 5-year view of Share-based Compensation shows it stood at $6.0 million in 2022, then slumped by 60.36% to $2.4 million in 2023, then sank by 46.27% to $1.3 million in 2024, then surged by 32.47% to $1.7 million in 2025, then tumbled by 76.68% to $392000.0 in 2026.
- Business Quant data shows JUSHF's Share-based Compensation at $392000.0 in Q1 2026, $1.7 million in Q4 2025, and $357000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 43.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 25.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 33.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -395,114.54 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 57.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 21.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 36.33 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 36.86 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 16.04 Mn |
| 10 | Jushi Holdings | - | - | 29.88 Mn | 392,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 392,000.00 |
| Mar 31, 2026 | 392,000.00 |
| Dec 31, 2025 | 1.68 Mn |
| Dec 31, 2025 | 1.68 Mn |
| Sep 30, 2025 | 357,000.00 |
| Sep 30, 2025 | 357,000.00 |
| Jun 30, 2025 | 374,000.00 |
| Jun 30, 2025 | 374,000.00 |
| Mar 31, 2025 | -307,000.00 |
| Mar 31, 2025 | -307,000.00 |
| Dec 31, 2024 | 1.27 Mn |
| Dec 31, 2024 | 1.27 Mn |
| Sep 30, 2024 | 1.08 Mn |
| Sep 30, 2024 | 1.08 Mn |
| Jun 30, 2024 | 347,000.00 |
| Jun 30, 2024 | 347,000.00 |
| Mar 31, 2024 | 1.52 Mn |
| Mar 31, 2024 | 1.52 Mn |
| Dec 31, 2023 | 2.36 Mn |
| Dec 31, 2023 | 2.36 Mn |